ERBB2 and breast neoplasm: Breast tumors were, therefore, classified according to the expression of several clinical biomarkers, such as estrogen (ER) and progesterone (PR) receptors and the human epidermal growth factor receptor 2 (HER2) gene amplification [12,13,14].